You are viewing the site in preview mode

Skip to main content

Table 1 Inclusion and exclusion criteria

From: Therapeutic effects of non-invasive, individualized, transcranial neuromodulation treatment for voiding dysfunction in multiple sclerosis patients: study protocol for a pilot clinical trial

Inclusion Exclusion
• Adult female (≥ 18 years old)
• Clinically stable MS (EDSS ≤ 6.5)
• Bladder symptoms ≥ 3 months
• VD diagnosis, defined as
o %PVR/BC > 40%, OR
o Liverpool Nomogram percentile < 10%, OR
o Perform self-catheterization
• Male
• Severe debilitating MS
• History of recent seizure (< 1 year)
• Pregnant or planning to become pregnant
• Contraindication to MRI
• History of augmentation cystoplasty
• Recent BTX-A injection (< 6 months)
• Other neurological disorders beside MS
\